A series of infections due to Capnocytophaga spp. in immunosuppressed and immunocompetent patients

被引:43
作者
Bonatti, H
Rossboth, DW
Nachbaur, D
Fille, M
Aspöck, C
Hend, I
Hourmont, K
White, L
Malnick, H
Allerberger, FJ
机构
[1] Univ Innsbruck, Dept Gen & Transplant Surg, A-6020 Innsbruck, Austria
[2] Univ Innsbruck, Inst Hyg, A-6020 Innsbruck, Austria
[3] Univ Innsbruck, Dept Clin Immunobiol, A-6020 Innsbruck, Austria
[4] Univ Innsbruck, BMT, Div Med, A-6020 Innsbruck, Austria
[5] Univ Vienna, Clin Inst Hosp Infect Control, Gen Hosp Vienna, Vienna, Austria
[6] Southmead Gen Hosp, UK NEQAS Antibiot Assays, Dept Microbiol, Southmead Hlth Serv NHS Trust, Bristol, Avon, England
[7] Cent Publ Hlth Lab, London NW9 5HT, England
关键词
Capnocytophaga; immunosuppression; immunocompetent; sepsis; empyema;
D O I
10.1046/j.1469-0691.2003.00538.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
ObjectiveTo investigate the epidemiology, microbiology and outcome of infections caused by Capnocytophaga spp. at a single center. Methods We report on ten documented infectious episodes caused by Capnocytophaga observed between 1994 and 1999 at the Innsbruck University Hospital. Results In seven of ten patients, Capnocytophaga septicemia was diagnosed during periods of neutropenia. In contrast, the remaining three patients had normal white blood cell counts when acquiring Capnocytophaga septicemia (one) and pleural empyema (two). Blood cultures containing long, slender, Gram-negative rods, which grew slowly under anaerobic conditions and lacked susceptibility to metronidazole, were subcultivated in a CO2-enriched atmosphere (5%). Subcultivation yielded Capnocytophaga in all ten cases within 2-12 days. The patients were then placed on appropriate antibiotic therapy, with or without additional surgical intervention, and the organism was eradicated. Conclusion Identification of Capnocytophaga facilitates appropriate, and in most cases effective, antimicrobial therapy.
引用
收藏
页码:380 / 387
页数:8
相关论文
共 22 条
[1]  
ANNE C, 2000, CURR OPIN INFECT DIS, V13, P361
[2]   INVITRO SUSCEPTIBILITY OF 96 CAPNOCYTOPHAGA STRAINS, INCLUDING A BETA-LACTAMASE PRODUCER, TO NEW BETA-LACTAM ANTIBIOTICS AND 6 QUINOLONES [J].
ARLET, G ;
SANSONLEPORS, MJ ;
CASIN, IM ;
ORTENBERG, M ;
PEROL, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (08) :1283-1284
[3]  
BAQUERO F, 1990, REV INFECT DIS, V12, pS157
[4]   CAPNOCYTOPHAGA BACTEREMIA IN A PATIENT WITH HODGKINS-DISEASE FOLLOWING BONE-MARROW TRANSPLANTATION - CASE-REPORT AND REVIEW [J].
BILGRAMI, S ;
BERGSTROM, SK ;
PETERSON, DE ;
HILL, DR ;
DAINIAK, N ;
QUINN, JJ ;
ASCENSAO, JL .
CLINICAL INFECTIOUS DISEASES, 1992, 14 (05) :1045-1049
[5]   Infectious complications of cirrhosis [J].
Brann O.S. .
Current Gastroenterology Reports, 2001, 3 (4) :285-292
[6]   CAPNOCYTOPHAGA-CANIMORSUS SP-NOV (FORMERLY CDC GROUP DF-2), A CAUSE OF SEPTICEMIA FOLLOWING DOG BITE, AND C-CYNODEGMI SP-NOV, A CAUSE OF LOCALIZED WOUND-INFECTION FOLLOWING DOG BITE [J].
BRENNER, DJ ;
HOLLIS, DG ;
FANNING, GR ;
WEAVER, RE .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (02) :231-235
[7]   Assessment of five culture media for the growth and isolation of Capnocytophaga spp. [J].
Caintar, M ;
Spratt, DA ;
Newman, HN ;
Wilson, M .
CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (03) :158-160
[8]  
Gill V. J., 2000, MANDELL DOUGLAS BENE, P2441
[9]  
Hourmont K, 2000, Surg Endosc, V14, P866
[10]   In vitro susceptibilities of Capnocytophaga isolates to β-lactam antibiotics and β-lactamase inhibitors [J].
Jolivet-Gougeon, A ;
Buffet, A ;
Dupuy, C ;
Sixou, JL ;
Bonnaure-Mallet, M ;
David, S ;
Cormier, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) :3186-3188